IP Library Granted Patent US 11,806,460
Granted Patent B2
US 11,806,460 · App. 16/706,317 · Granted Nov 7, 2023

Syringe warmer

Inventors: David Yuds (Hudson, NH); Samiullah K. Durrani (Harvard, MA); Martin Joseph Crnkovich (Walnut Creek, CA)
Assignee: Fresenius Medical Care Holdings, Inc.
A61M1/3646A61M1/1629A61M1/3413A61M1/3424A61M2205/3331A61M2205/3368A61M2205/368
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,806,460
App. No.
16/706,317
Granted
Nov 7, 2023
Kind
B2
Abstract

A method includes, after an extracorporeal blood treatment, connecting a fluid source to an access line that is connected to a patient, and delivering a fluid from the fluid source to the access line to infuse blood from the access line to the patient, wherein the fluid delivered to the access line has a temperature from about 30 degrees Celsius to about 38 degrees Celsius.

Claims (32)

1. An extracorporeal blood treatment apparatus comprising:

a housing that receives a syringe; and

a heating element coupled to the housing and configured to heat a fluid in the syringe, wherein:

the syringe is filled with the fluid and the fluid is received from a fluid line of an extracorporeal blood treatment system;

the syringe is coupled to an access line that is connected to a patient after an extracorporeal blood treatment; and

the fluid in the syringe is delivered to the access line to infuse blood from the access line to the patient after the extracorporeal blood treatment, wherein the fluid delivered to the access line has a temperature from about 30 degrees Celsius to about 38 degrees Celsius.

2. A method comprising:

filling a syringe with a fluid received from a fluid line of an extracorporeal blood treatment system;

after an extracorporeal blood treatment, connecting the syringe to an access line that is connected to a patient; and

delivering the fluid from the syringe to the access line to infuse blood from the access line to the patient, wherein the fluid delivered to the access line has a temperature from about 30 degrees Celsius to about 38 degrees Celsius.

3. The method of claim 2 , further comprising heating the fluid contained in the syringe.

4. The method of claim 3 , wherein heating the fluid contained in the syringe comprises positioning the syringe proximate a heating element.

5. The method of claim 4 , wherein heating the fluid contained in the syringe comprises activating the heating element prior to performing extracorporeal treatment.

6. The method of claim 4 , wherein heating the fluid contained in the syringe comprises positioning the syringe in a housing coupled to an extracorporeal blood treatment apparatus, wherein the housing comprises the heating element.

7. The method of claim 4 , wherein heating the fluid contained in the syringe comprises positioning the syringe proximate a dialyzer of the extracorporeal blood treatment system.

8. The method of claim 4 , wherein heating the fluid contained in the syringe comprises positioning the syringe proximate a second fluid line of the extracorporeal blood treatment system.

9. The method of claim 8 , wherein the second fluid line comprises a dialysate line carrying dialysate fluid to a dialyzer of the extracorporeal blood treatment system.

10. The method of claim 2 , wherein:

the fluid line comprises a substitution line coupled to a extracorporeal blood treatment apparatus of the extracorporeal blood treatment system; and

the fluid comprises substitution fluid.

11. The method of claim 2 , wherein filling the syringe comprises:

connecting the syringe to the fluid line of the extracorporeal blood treatment system; and

actuating a plunger of the syringe to draw fluid from the fluid line into the syringe.

12. The method of claim 2 , wherein the fluid comprises saline.

13. The method of claim 2 , wherein connecting the syringe to the access line comprises connecting the syringe to an end of the access line.

14. The method of claim 2 , wherein filling the syringe comprises connecting the syringe to the fluid line of the extracorporeal blood treatment system.

15. The method of claim 14 , wherein:

the fluid line comprises a saline line coupled to a saline bag of the extracorporeal blood treatment system; and

the fluid comprises saline.

16. The method of claim 14 , wherein:

the fluid line comprises a substitution line coupled to a extracorporeal blood treatment apparatus of the extracorporeal blood treatment system; and

the fluid comprises substitution fluid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2020
From: YUDS, DAVID; DURRANI, SAMIULLAH K.; CRNKOVICH, MARTIN JOSEPH
To: FRESENIUS MEDICAL CARE HOLDINGS, INC.
Reel/Frame 052006/0025 →
Continuity (1)
Related Publication 20210170090A1 · Jun 10, 2021